Related Experiment Video

Updated: Jun 8, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines

Derek Horton1, Anakshi Khare

  • 1Department of Chemistry, American University, 4400 Massachusetts Avenue, NW, Washington, DC 20016, USA. carbchm@american.edu

Bioorganic & Medicinal Chemistry Letters
|September 21, 2010
PubMed

Insights

Four novel anthracycline analogs were tested against human tumor cell lines. Compound 4 demonstrated potent growth-inhibitory effects, showing efficacy comparable or superior to adriamycin (doxorubicin).

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Anthracyclines like adriamycin (doxorubicin) are vital chemotherapeutics.
  • Developing novel analogs with improved efficacy and reduced toxicity is crucial.
  • Existing anthracyclines face challenges like drug resistance and side effects.

Purpose of the Study:

  • To synthesize and evaluate novel anthracycline analogs.
  • To compare their in vitro growth-inhibitory effects against various human tumor cell lines.
  • To identify analogs with potential as superior anticancer agents.

Main Methods:

  • Synthesis of four distinct anthracycline analogs.
  • In vitro cytotoxicity assays using five human tumor cell lines (lung carcinoma, colon adenocarcinoma, breast adenocarcinoma, melanoma, glioblastoma).
  • Comparative analysis of growth inhibition against adriamycin (doxorubicin).

Main Results:

  • Compounds 1, 2, and 3 exhibited moderate cytotoxic effects across most cell lines.
  • Compound 4 demonstrated significant growth inhibition, comparable or superior to adriamycin.
  • Compound 4 showed potent activity against lung carcinoma, colon adenocarcinoma, breast adenocarcinoma, melanoma, and glioblastoma cell lines.

Conclusions:

  • Compound 4, a 14-hydroxy analog, is a promising candidate for further anticancer drug development.
  • The novel anthracycline analogs warrant further investigation for their therapeutic potential.
  • Structure-activity relationships suggest the 14-hydroxy modification enhances cytotoxic potency.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...